At the heart of the Golden State, nestled within the vibrant cityscape of San Francisco, lies Emily Willow's state-of-the-art psychiatric practice. Committed to providing the best in cutting-edge treatment, her practice specializes in managing a spectrum of mental health disorders including depression, anxiety, PTSD, and obsessive-compulsive disorder. Dr. Willow's expertise extends beyond the conventional, bridging the gap between traditional psychiatry and the fascinating world of personal growth and psychotherapeutic exploration. As a featured provider at the renowned Kriya Institute, her specialized methods incorporate progressive techniques such as short-term, goal-focused psychotherapy and psychedelic coaching, which are designed to empower her patients in maximizing the potential benefits of their previous psychedelic experiences.

Emily Willow, MD, formerly known as Emily Williams, MD, is a board-certified psychiatrist, esteemed researcher, and passionate educator. She is at the forefront of psychedelic medicine advocacy, engrossed in clinical trials that focus on the impact of psychedelic-assisted psychotherapy, specifically examining the therapeutic effects of MDMA and psilocybin. Besides heading her private practice, Dr. Willow takes on numerous roles: she is a part of the clinical research team for the Multidisciplinary Association for Psychedelic Studies (MAPS) affiliated with the San Francisco Insight and Integration Center, and she serves as an attending psychiatrist at both the University of California, San Francisco and Zuckerberg SF General Hospital in Psychiatric Emergency Services. Additionally, Dr. Willow nourishes the next generation of therapists through her mentorship and teaching roles at the California Institute of Integral Studies, in both the Center for Psychedelic Therapies and Research and the School of Consciousness and Transformation.